Comparing ablation and defibrillator for well-tolerated ventricular tachycardia in ischemic heart disease
Compares heart rhythm ablation with a defibrillator in adults with ischemic heart disease and tachycardia.
Plain-language title generated from the registry record
Registry title: International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction
Key facts
- Where
- Toulouse, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had a heart attack, have a well-tolerated fast heart rhythm from the lower chambers (ventricular tachycardia), and a mildly reduced pumping strength of the heart.
- Age
- 18 to 90 years
- Sex
- All sexes can join.
- Disease stage
- Heart disease caused by poor blood supply with a past heart attack. Heart pumping strength (LVEF) above 35%, measured by MRI. Lasting, regular fast heartbeat of the lower chambers (sustained monomorphic ventricular tachycardia) with no past fainting or cardiac arrest.
Main reasons for not taking part
- A temporary, reversible cause of the fast heartbeat
- A heart attack in the last 2 months
- Fast heartbeat caused by a circuit from branch to branch of the heart's conduction system
- Serious conduction problems of the heart that need a pacemaker
- Reasons that rule out a defibrillator or an ablation (life expectancy under 1 year, relevant other illnesses), or pregnancy
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06294028, who can take part
Where in France
- Rangueil hospitalToulouse, FranceContact: Philippe MD MAURYTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Toulouse
- Trial code
- NCT06294028
- Record updated
- 1 June 2026
- Original description
Evidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without cardiocirculatory arrest or syncope) is lacking, as no previous trials have included such patients. Additionally, sudden death in this particular population is low compared to other subgroups of patients with malignant ventricular arrhythmias.Read full original descriptionShow less
International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction
Evidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without cardiocirculatory arrest or syncope) is lacking, as no previous trials have included such patients. Additionally, sudden death in this particular population is low compared to other subgroups of patients with malignant ventricular arrhythmias.
On the other hand, numerous recent retrospective data show that ablation of ventricular tachycardia can reduce mortality, and also clearly reduces the number of recurrences in prospective studies.
Finally, a very low rate of sudden death was observed in a multicenter European retrospective study that we conducted, including patients with well-tolerated ventricular tachycardia in structural heart disease with minimally impaired ejection fraction and benefiting from ablation without implantation of defibrillator.
Inclusion: ischemic heart disease with history of infarction - LVEF> 35% (measured by MRI); sustained monomorphic ventricular tachycardia - without history of syncope or cardiac arrest -; having signed informed consent; affiliated to a social security system.
Exclusion: recent myocardial infarction (<2 months); age <18 years; transient regressive cause of ventricular tachycardia; ventricular tachycardia by reentry from branch to branch; serious conduction disturbances (with indication of stimulation); contraindication to the implantation of a defibrillator or to the performance of an ablation (life expectancy <1 year, relevant comorbidities); pregnancy; Patient under legal protection, guardianship or curatorship.